Lu Xue
Changchun, 130021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction: Yu et al. Non-Cationic RGD-Containing Protein Nanocarrier for Tumor-Targeted siRNA Delivery. Pharmaceutics 2021, 13, 2182.
Journal: Pharmaceutics
Published: October 31, 2025
Targeted Delivery of AR-V7 siRNA with Bivalent PSMA Aptamers Effectively Suppresses the Growth of Enzalutamide-Resistant Prostate Cancer.
Journal: Molecular pharmaceutics
Published: October 10, 2024
Structural-functional diversity of CD47 proteoforms.
Journal: Frontiers in immunology
Published: October 29, 2023
Non-Cationic RGD-Containing Protein Nanocarrier for Tumor-Targeted siRNA Delivery.
Journal: Pharmaceutics
Published: October 21, 2021
KDM4C contributes to cytarabine resistance in acute myeloid leukemia via regulating the miR-328-3p/CCND2 axis through MALAT1.
Journal: Therapeutic advances in chronic disease
Published: January 22, 2021
Synergistic Targeting HER2 and EGFR with Bivalent Aptamer-siRNA Chimera Efficiently Inhibits HER2-Positive Tumor Growth.
Journal: Molecular pharmaceutics
Published: September 18, 2018
Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity against HER2+ Breast Cancer.
Journal: Molecular therapy. Nucleic acids
Published: December 21, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026